Symmetry Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,202
| Closed | -$214K | – | 542 |
|
|
2023
Q4 | $214K | Sell |
2,202
-546
| -20% | -$53.1K | 0.01% | 477 |
|
|
2023
Q3 | $243K | Hold |
2,748
| – | – | 0.01% | 470 |
|
|
2023
Q2 | $238K | Hold |
2,748
| – | – | 0.01% | 520 |
|
|
2023
Q1 | $267K | Hold |
2,748
| – | – | 0.01% | 473 |
|
|
2022
Q4 | $284K | Hold |
2,748
| – | – | 0.02% | 474 |
|
|
2022
Q3 | $233K | Hold |
2,748
| – | – | 0.02% | 500 |
|
|
2022
Q2 | $228K | Hold |
2,748
| – | – | 0.02% | 511 |
|
|
2022
Q1 | $212K | Hold |
2,748
| – | – | 0.01% | 559 |
|
|
2021
Q4 | $243K | Hold |
2,748
| – | – | 0.02% | 560 |
|
|
2021
Q3 | $211K | Hold |
2,748
| – | – | 0.01% | 625 |
|
|
2021
Q2 | $229K | Hold |
2,748
| – | – | 0.02% | 624 |
|
|
2021
Q1 | $208K | Sell |
2,748
-17
| -0.6% | -$1.29K | 0.01% | 621 |
|
|
2020
Q4 | $242K | Buy |
2,765
+11
| +0.4% | +$963 | 0.02% | 558 |
|
|
2020
Q3 | $210K | Buy |
+2,754
| New | +$210K | 0.02% | 560 |
|